RCUS — ARCUS BIOSCIENCES INC

Ownership history in MACQUARIE GROUP LTD  ·  22 quarters on record

This page tracks every 13F SEC filing in which MACQUARIE GROUP LTD reported a position in ARCUS BIOSCIENCES INC (RCUS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2021 Q1)
Avg. % of fund
0.01%
First filed
2020 Q2
Last filed
2025 Q3
Quarters held
22
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 379,100 — 0% 0.01% $5.2M $13.60
2025 Q2 UNCHANGED 379,100 — 0% 0.00% $3.1M $8.14
2025 Q1 UNCHANGED 379,100 — 0% 0.00% $3.0M $7.85
2024 Q4 UNCHANGED 379,100 — 0% 0.01% $5.6M $14.89
2024 Q3 UNCHANGED 379,100 — 0% 0.01% $5.8M $15.29
2024 Q2 UNCHANGED 379,100 — 0% 0.01% $5.8M $15.23
2024 Q1 UNCHANGED 379,100 — 0% 0.01% $7.2M $18.88
2023 Q4 UNCHANGED 379,100 — 0% 0.01% $7.2M $19.10
2023 Q3 UNCHANGED 379,100 — 0% 0.01% $6.8M $17.95
2023 Q2 UNCHANGED 379,100 — 0% 0.01% $7.7M $20.31
12 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RCUS price (monthly, adj. close)

Other funds also holding RCUS

As of 2025 Q4 — sorted by position size

GILEAD SCIENCES, INC. 38.69% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 2.53% DAFNA Capital Management LLC 3Y 7Y 2.39% Parkman Healthcare Partners LLC 3Y 2.2% Siren, L.L.C. 2.14% Decheng Capital LLC 1.74% First Turn Management, LLC 1.54% Logos Global Management LP 3Y 1.51% Knott David M Jr 3Y 1.34% Sofinnova Investments, Inc. 3Y 7Y 1.13%
← Back to MACQUARIE GROUP LTD Holdings